Axiall Corp  

(Public, NYSE:AXLL)   Watch this stock  
Find more results for NYSE:GGC
18.74
-0.51 (-2.65%)
Feb 5 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 18.27 - 19.61
52 week 9.04 - 51.35
Open 18.27
Vol / Avg. 1.71M/2.23M
Mkt cap 1.32B
P/E     -
Div/yield 0.16/3.42
EPS -11.04
Shares 70.58M
Beta 2.67
Inst. own 103%
Feb 16, 2016
Q4 2015 Axiall Corp Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Dec 1, 2015
Axiall Corp at Citi Basic Materials Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -91.21% 1.10%
Operating margin -92.78% 2.94%
EBITD margin - 9.56%
Return on average assets -61.74% 0.87%
Return on average equity -151.33% 1.82%
Employees 6,000 -
CDP Score - -

Address

1000 Abernathy Rd Ste 1200
ATLANTA, GA 30328-5653
United States - Map
+1-770-3954500 (Phone)
+1-770-3954529 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Axiall Corporation is a manufacturer and international marketer of chemicals and building products. The Company operates through three segments: chlorovinyls, building products and aromatics. The Company's chlorovinyls segment produces a chain of products, including chlor-alkali and derivative products, such as chlorine, caustic soda, vinyl chloride monomer (VCM), vinyl resins, ethylene dichloride (or 1, 2 dichloroethane) (EDC), chlorinated solvents, calcium hypochlorite, hydrochloric acid (HCL) and phosgene derivatives, and compound products, such as vinyl compounds and compound additives and plasticizers. The Company's building products segment consists of two primary product groups: window and door profiles and trim, moldings and deck products, and outdoor building products, which includes siding and exterior accessories, pipe and pipe fittings. The Company's aromatics segment manufactures cumene products and phenol and acetone products (co-products made from cumene).

Officers and directors

Timothy Mann Jr. President, Chief Executive Officer, General Counsel, Corporate Secretary, Director
Age: 50
Bio & Compensation  - Reuters
Gregory C. Thompson Chief Financial Officer
Age: 59
Bio & Compensation  - Reuters
Simon Bates Senior Vice President
Age: 49
Bio & Compensation  - Reuters
William H. Doherty Senior Vice President - Chemicals
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Dean A. Adelman Vice President - Human Resources
Age: 49
Bio & Compensation  - Reuters
Mark L. Noetzel Non-Executive Independent Chairman of the Board
Age: 57
Bio & Compensation  - Reuters
Michael H. McGarry Director
Age: 57
Bio & Compensation  - Reuters
T.Kevin DeNicola Independent Director
Age: 60
Bio & Compensation  - Reuters
Patrick J. Fleming Independent Director
Age: 71
Bio & Compensation  - Reuters
Robert M. Gervis Independent Director
Age: 54
Bio & Compensation  - Reuters